MINNEAPOLIS (March 29, 2017) – DaVita Clinical Research (DCR), a specialty contract research organization (CRO) with services spanning the full spectrum of drug and device development, has been recognized by Life Science Leader in multiple award categories of its 2017 CRO Leadership Awards.
“DCR is devoted to its customers and committed to becoming the service provider of choice,” said Amy Young, vice president and general manager of DaVita Clinical Research. “We are delighted to be recognized by Life Science Leader’s CRO Leadership Awards for the second consecutive year.”
Now in its fifth year since developing the CRO Leadership Awards, Life Science Leader worked with Industry Standard Research (ISR) to determine award recipients, providing readers with accurate and reliable customer feedback to assist them in choosing a reputable partner for their clinical research needs. Winners are determined after being judged by their customers as either exceeding expectations or as top performers in five award categories: capabilities, compatibility, expertise, quality and reliability.
DCR received an award in each of the five categories. The awards also encompassed all three groups of Big Pharma, Small Pharma and Overall. DCR’s winning categories include:
Capabilities (Overall, Big Pharma, Small Pharma)
Compatibility (Overall, Big Pharma, Small Pharma)
Expertise (Overall, Big Pharma, Small Pharma)
Quality (Overall, Big Pharma, Small Pharma)
Reliability (Overall, Big Pharma, Small Pharma)
The winning CROs outperformed on 27 different metrics, as rated by decision-making executives at biopharmaceutical companies. Survey participants were recruited from pharmaceutical and biopharmaceutical companies of all sizes and were screened for decision-making influence related to working with CROs. Respondents only evaluate companies they’ve worked with on an outsourced project within the past 18 months, ensuring survey responses are based on actual involvement with CROs and clear experiential data.
“Life Science Leader is proud to be working with ISR Reports to honor those CROs that have proven themselves to be the top performers in the five categories,” said Ed Miseta, executive editor of Life Science Leader. “The CROs receiving an award this year are truly at the top of their class, and are deserving of the recognition they receive. Being a top performer in any of these categories shows a level of expertise and commitment to clinical trials and serving the needs of biopharmaceutical companies and their patients.”
To learn more about DCR, visit www.DaVitaClinicalResearch.com.
About DaVita Clinical Research
DaVita Clinical Research (DCR), a wholly owned subsidiary of DaVita Inc., uses its extensive, applied database and real-world healthcare experience to assist pharmaceutical and medical device companies in the design, recruitment and completion of retrospective, prospective and pragmatic clinical trials. DCR’s scientific and clinical expertise spans the lifecycle of product development with more than 175 client companies. DCR’s Early Clinical Research unit (Phase I-IIa) and Late Phase Clinical Research (Phase IIb through post-marketing) network of physicians and investigative sites, and Real-World Healthcare Data are focused on providing world-class research in both complex/specialty populations and therapeutic areas and especially in CKD and ESRD populations. To learn more about DCR, visit www.davitaclinicalresearch.com.
About DaVita Inc.
DaVita Inc., a Fortune 500® company, is the parent company of DaVita Kidney Care and HealthCare Partners. DaVita Kidney Care is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. As of December 31, 2016, DaVita Kidney Care operated or provided administrative services at 2,350 outpatient dialysis centers located in the United States serving approximately 188,000 patients. The company also operated 154 outpatient dialysis centers located in 11 countries outside the United States. HealthCare Partners, a DaVita Medical Group, manages and operates medical groups and affiliated physician networks in California, Nevada, New Mexico, Florida, Colorado and Washington in its pursuit to deliver excellent-quality health care in a dignified and compassionate manner. As of December 31, 2016, HealthCare Partners provided integrated care management for approximately 749,000 patients. For more information, please visit DaVita.com/about.